Vimarsana
Biggest News Aggregation in the World

Page 2 - Flu Severe News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Flu Severe. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Flu Severe Today - Breaking & Trending Today

Decongestants: Lawsuit over useless meds seeks money for consumers - Vimarsana News

Decongestants: Lawsuit over useless meds seeks money for consumers

At issue are the compound phenylephrine and at least 250 products containing it, from Sudafed Sinus Congestion to Tylenol Cold & Flue Severe to Nyquil Severe Cold & Flu, plus generic brands developed by companies such as CVS, Walmart and Target.

After decongestants found ineffective, California lawsuit seeks money for anyone who bought useless products - Vimarsana News

After decongestants found ineffective, California lawsuit seeks money for anyone who bought useless products

At issue are the compound phenylephrine and at least 250 products containing it, from Sudafed Sinus Congestion to Tylenol Cold & Flue Severe to Nyquil Severe Cold & Flu, plus generic brands developed by companies such as CVS, Walmart and Target.

Key Ingredient in Most Decongestants Doesn't Work, Experts Say - Vimarsana News

Key Ingredient in Most Decongestants Doesn't Work, Experts Say

The key ingredient that underpins many nasal decongestants don't work as promised when taken orally.

Decongestant in common cold medicines doesn't work, FDA says. Here's what to take instead - Vimarsana News

Decongestant in common cold medicines doesn't work, FDA says. Here's what to take instead

If the agency decides to ban the ingredient, it could mean products for both kids and adults will be pulled from shelves.

Source: yahoo.com
Oral Decongestant Phenylephrine Doesn't Work, FDA Says - Vimarsana News

Oral Decongestant Phenylephrine Doesn't Work, FDA Says

Scientists have known for years phenylephrine is ineffective. Now it might be pulled from the market.